ArticleClinical science (London, England : 1979)2021

Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese mice.

Osvaldo Rivera-Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.